HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hsin-Yen Cho Selected Research

Isoquinolines

11/2021The Effectiveness in Activating M-Type K+ Current Produced by Solifenacin ([(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate): Independent of Its Antimuscarinic Action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hsin-Yen Cho Research Topics

Disease

1Neuralgia (Stump Neuralgia)
03/2022
1Diabetic Neuropathies (Diabetic Neuropathy)
03/2022
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
12/2021
1Urinary Incontinence
11/2021
1Pituitary Neoplasms (Pituitary Adenoma)
10/2021
1Neoplasms (Cancer)
10/2021

Drug/Important Bio-Agent (IBA)

1mirogabalinIBA
03/2022
1sparsentanIBA
12/2021
1Endothelins (Endothelin)IBA
12/2021
1Angiotensin IIIBA
12/2021
1Polymethyl Methacrylate (Sol)IBA
11/2021
1Solifenacin SuccinateFDA Link
11/2021
1IsoquinolinesIBA
11/2021
1Cholinergic Antagonists (Anticholinergics)IBA
11/2021
1Muscarinic AntagonistsIBA
11/2021
11-octylnonyl 8- ((2- hydroxyethyl)(6- oxo- 6- (undecyloxy)hexyl)amino)octanoateIBA
10/2021